Lakefront BiotherapeuticsvsThermo Fisher Scientific

LKFT and TMO stock compared: price, dividend, valuation and results, from SEC filings.

LKFT

Lakefront Biotherapeutics

$33.31

Value $2.2B

-0.24%
LKFT's page

TMO

Thermo Fisher Scientific Inc

$669.54

Value $249B

-2.79%
TMO's page

Lakefront Biotherapeutics (LKFT) has a market value of $2.2B and Thermo Fisher Scientific (TMO) $249B. Over the last year, with dividends, LKFT moved +9.2% and TMO +17.1%. The P/E is 5.8 for LKFT and 35.2 for TMO. Dividend yield: LKFT none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LKFT$2.2B

    TMO$249B

    TMO is 113 times LKFT

  • Revenue, 12 months

    LKFT$1.3B

    TMO$47.4B

    TMO is 36 times LKFT

  • Net income, 12 months

    LKFT$377M

    TMO$7.1B

    TMO is 19 times LKFT

  • Operating margin

    LKFT26.5%

    TMO17.9%

    8.6 points apart

  • ROIC

    LKFT7.2%

    TMO8.2%

    1.0 points apart

  • P/E

    LKFT5.8

    TMO35.2

    TMO is 6.0 times LKFT

  • Dividend yield

    LKFT0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    LKFT-35.3%

    TMO+6.8%

    42.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LKFT-35.3%

TMO+6.8%

5010020222023202420252026
Returns by period
PeriodLKFTWith dividendsTMOWith dividends
1 year since November 19, 2025+9.2%Price +9.2%+17.1%Price +16.7%
3 years since November 20, 2023-10.9%-3.8% a yearPrice -10.9%+44.1%+13.0% a yearPrice +42.7%
5 years since November 19, 2021-35.3%-8.3% a yearPrice -35.3%+6.8%+1.3% a yearPrice +5.3%
10 years since November 22, 2016-42.5%-5.4% a yearPrice -42.5%+381.6%+17.0% a yearPrice +368.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LKFTLakefront BiotherapeuticsTMOThermo Fisher Scientific

Valuation

LKFTTMO
Valuation
Price$33.31$669.54
Market value$2.2B$249B
Enterprise value (EV)$2.1B$284B
P/E5.835.2
P/E, 5-year median11.532.7
P/B0.64.5
EV/EBIT6.133.5
Free cash flow yield–3.1%

Results and growth

LKFTTMO
Results and growth
Revenue, 12 months$1.3B$47.4B
Net income, 12 months$377M$7.1B
Free cash flow, 12 months-$318M$7.6B
Earnings per share, 12 months$5.72$18.96
Revenue growth, year on year303.5%3.9%
Revenue growth a year, past+18.4%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

LKFTTMO
Margins and returns on capital
Gross margin97.3%–
Operating margin26.5%17.9%
Net margin28.8%14.9%
ROIC7.2%8.2%
ROE9.9%13.4%

Balance sheet

LKFTTMO
Balance sheet
Cash$103M$6.1B
Total debt$8.1M$41.4B
Net debt / EBITDA–3.7
Interest cover–5.5×

Dividends and buybacks

LKFTTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LKFT or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Lakefront Biotherapeutics or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($249B) is about 113.3 times Lakefront Biotherapeutics ($2.2B), at today's prices.

How did LKFT and TMO stock do over the last 10 years?

Since November 22, 2016, LKFT's price moved -42.5% and TMO's +368.2%. With dividends: LKFT -42.5% (-5.4% a year), TMO +381.6% (+17.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, LKFT or TMO?

The dividend yield at today's price is none for Lakefront Biotherapeutics and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of LKFT and TMO?

At today's price, the P/E is 5.8 for LKFT and 35.2 for TMO. The median of the last five years was 11.5 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Lakefront Biotherapeutics or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 28.8% for Lakefront Biotherapeutics and 14.9% for Thermo Fisher Scientific, and the operating margin 26.5% and 17.9%. Revenue was $1.3B and $47.4B.

Which is the better investment, Lakefront Biotherapeutics or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.